We are live on ! Find out more
Point72 Asset Management

Point72 Asset Management Portfolio holdings

AUM $78.1B
1-Year Est. Return 55.25%
This Fund
S&P 500
This Quarter Est. Return
+10.77%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$19.5B
AUM Growth
+$4.2B
Cap. Flow
+$3.06B
Cap. Flow %
15.66%
Top 10 Hldgs %
15.97%
Holding
1,184
New
406
Increased
253
Reduced
226
Closed
288

Sector Composition

Rank Sector Weight
1 Healthcare 22.23%
2 Technology 20.39%
3 Consumer Discretionary 13.52%
4 Financials 8.95%
5 Communication Services 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACMR icon
901
ACM Research
ACMR
$5.61B
-37,746
Closed -$785K
ADBE icon
902
Adobe
ADBE
$100B
-1,529
Closed -$666K
ADT icon
903
ADT
ADT
$5.67B
-249,064
Closed -$1.99M
AEP icon
904
American Electric Power
AEP
$69.1B
-606,704
Closed -$48.3M
AIG icon
905
American International
AIG
$41.5B
-244,103
Closed -$7.61M
AJG icon
906
Arthur J. Gallagher & Co
AJG
$62.8B
-14,376
Closed -$1.4M
AKBA icon
907
Akebia Therapeutics
AKBA
$357M
-734,028
Closed -$9.97M
ALEC icon
908
Alector
ALEC
$169M
-288,263
Closed -$7.04M
ALL icon
909
Allstate
ALL
$66.9B
-81,471
Closed -$7.9M
ANAB icon
910
AnaptysBio
ANAB
$1.59B
-210,886
Closed -$4.71M
API
911
Agora
API
$344M
-30,000
Closed -$1.32M
APVO icon
912
Aptevo Therapeutics
APVO
$4.92M
0
-$1.32M
ARCT icon
913
Arcturus Therapeutics
ARCT
$168M
-223,013
Closed -$10.4M
ARGX icon
914
argenx
ARGX
$52.3B
-42,574
Closed -$9.59M
ASH icon
915
Ashland
ASH
$3.28B
-84,153
Closed -$5.82M
ATI icon
916
ATI
ATI
$26.8B
-774,327
Closed -$7.89M
ATRA icon
917
Atara Biotherapeutics
ATRA
$77M
-5,310
Closed -$1.93M
AVA icon
918
Avista
AVA
$3.26B
-28,012
Closed -$1.02M
AWI icon
919
Armstrong World Industries
AWI
$7.63B
-1,249
Closed -$97K
AXTA icon
920
Axalta
AXTA
$7.97B
-90,600
Closed -$2.04M
BC icon
921
Brunswick
BC
$5.3B
-38,458
Closed -$2.46M
BFH icon
922
CALL
Bread Financial
BFH
$4.58B
-375,900
Closed -$13.5M
BHF icon
923
Brighthouse Financial
BHF
$3.6B
-57,700
Closed -$1.6M
BIDU icon
924
Baidu
BIDU
$38.1B
-133,609
Closed -$16M
BIO icon
925
Bio-Rad Laboratories Class A
BIO
$8.8B
-14,305
Closed -$6.46M

Similar funds

Point72 Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Point72 Asset Management held 1,184 positions worth $19.5B, up 27% from $15.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Point72 Asset Management deployed $3.06B of net new capital in Q3 2020, opening 406 new positions and adding to 253 existing holdings. Its largest new stake was Palantir: 29,904,230 shares worth $284M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Immunomedics Inc, an estimated $205M trimmed.

  • Point72 Asset Management's largest Q3 2020 buy was Palantir: 29,904,230 shares worth $284M.
  • Point72 Asset Management added most to Alphabet (Google) Class A in Q3 2020, an estimated $243M increase.
  • Point72 Asset Management's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $205M.
  • Point72 Asset Management fully exited Salesforce in Q3 2020, selling an estimated $105M.
  • Point72 Asset Management's ten largest holdings make up 16% of its $19.5B portfolio in Q3 2020.
  • Point72 Asset Management opened 406 new positions and closed 288 in Q3 2020.
  • Point72 Asset Management's portfolio value rose 27% quarter-over-quarter to $19.5B.

Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.